Our NAV-005 antagonist binds the immunosuppressive HIO-1 factor and blocks its ability to suppress mAb, TCE and ADC ...

Hippocampi- targeted AAV-delivered BDNF gene therapy improves cognitive impairments in Alzheimer’s disease Alzheimer’s ...

Learn which nanocarriers matter now (LNPs, exosomes, polymers) and the key hurdles in biodistribution, safety, CMC, and ...

The deal underscores a broader shift in autoimmune drug development toward therapies that aim to reprogram disease-driving ...

Chordoma is a rare tumor characterized by poor prognosis, limited therapeutic options, and a high rate of recurrence. Despite ...

Engineered BiTE molecule draws T cells to eliminate FAP+ modulated smooth muscle cells, reducing plaque burden across mouse atherosclerosis models.

The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with NSCLC, RCC, colorectal cancer ...

Chordoma is a rare, treatment-resistant tumor with limited therapeutic options and a high rate of recurrence. In a recent ...

Around 10 percent of people who take statins to lower cholesterol experience mysterious muscle pains, causing many to discontinue these potentially life-saving medicines. Now, researchers from ...

Viruses attack nearly every living organism on Earth. To do so, they rely on highly specialized proteins that recognize and ...

The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number ...